Underutilization of isoniazid drug therapy to prevent TB disease progression in Swaziland

Underutilization of isoniazid drug therapy to prevent TB disease progression in Swaziland

Bibliographic Details
Main Authors:	B. Cronin, M. Calnan, S. Haumba, L.V. Adams
Format:	Article
Language:	English
Published:	Levy Library Press 2015-03-01
Series:	Annals of Global Health
Online Access:	https://annalsofglobalhealth.org/articles/1546

Similar Items

Delivery of isoniazid preventive therapy to reduce occupational TB among healthcare workers in Swaziland
by: Marianne Calnan, et al.
Published: (2017-03-01)

A case- control study on risk factors associated with isoniazid resistant TB among HIV positive TB patients in Swaziland
by: Nonhlanhla Christinah Dlamini, et al.
Published: (2017)

Review of outcomes for isoniazid preventive therapy among HIV infected clients at a clinic in Swaziland
by: Musarapasi, Normusa
Published: (2019)

The impact of isoniazid preventative therapy and antiretroviral therapy on tuberculosis (TB) in HIV-infected children in a high TB incidence setting
by: Frigati, Lisa Jane
Published: (2014)

High uptake of antiretroviral therapy among HIV-positive TB patients receiving co-located services in Swaziland.
by: Ishani Pathmanathan, et al.
Published: (2018-01-01)

Computational approach to understanding the mechanism of action of isoniazid, an anti-TB drug
by: Lingaraja Jena, et al.
Published: (2014-01-01)

Uptake of Isoniazid Preventive Therapy among Under-Five Children: TB Contact Investigation as an Entry Point.
by: Yared Tadesse, et al.
Published: (2016-01-01)

Drug-related pellagra in a Ugandan woman on isoniazid preventative therapy
by: Sarah J. Coates, et al.
Published: (2020-01-01)

Pellagra in isoniazid preventive and antiretroviral therapy
by: John Koech Kipsang, et al.
Published: (2019-01-01)

Hyperglycaemia induced by isoniazid preventive therapy
by: Roshni Jhan Ganguly, et al.
Published: (2018-01-01)

Isoniazid preventative therapy uptake for child household contacts of TB index cases, Kisumu County, Kenya, 2014-2015
by: Barbara Burmen, et al.
Published: (2018-05-01)

Determinants of Cervical Cancer Screening in HIV-Positive Young Women in Swaziland
by: Calnan, Marianne
Published: (2019)

Isoniazid and acetylisoniazid urine concentrations as a maker of adherence to isoniazid preventative therapy in children
by: Amlabu, Veronica Asibi
Published: (2014)

Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis
by: Maria Elvira Balcells, et al.
Published: (2006-05-01)

Efficacy and safety of isoniazid preventive therapy in light of increasing multi-drug resistance in tuberculosis
by: Lingaraja Jena, et al.
Published: (2015-01-01)

Formulation of dispersible isoniazid/pyridoxine fixed-dose combination tablets for isoniazid preventive therapy in pediatrics
by: M. W. Mwangi, et al.
Published: (2020-01-01)

An evaluation of the isoniazid preventive therapy initiation in Limpopo province
by: Khota, Mmankhuma Joyce
Published: (2019)

Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania
by: Olivia F. Hunter, et al.
Published: (2020-10-01)

Outcomes and impact of HIV prevention, ART and TB programs in Swaziland--early evidence from public health triangulation.
by: Cari van Schalkwyk, et al.
Published: (2013-01-01)

Simultaneous detection of TB and drug resistance to Isoniazid in Mycobacterium tuberculosis clinical isolates using PCR-RFLP method
by: Maryam alsadat Tayeboon, et al.
Published: (2015-07-01)

Safety of long-term isoniazid preventive therapy in children with HIV
by: Le Roux, Stanzi Maria
Published: (2014)

Eligibility for isoniazid preventive therapy in South African gold mines.
by: James J Lewis, et al.
Published: (2013-01-01)

Best practice guidelines to monitor and prevent hearing loss related to drug resistant tuberculosis treatment
by: Haumba, Samson Malwa
Published: (2016)

Correction to: Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania
by: Olivia F. Hunter, et al.
Published: (2020-10-01)

Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania.
by: Paolo Denti, et al.
Published: (2015-01-01)

Drug abuse in adolescents in Swaziland
by: Mhlongo, Gladys Thembinkosi
Published: (2009)

Drug abuse in adolescents in Swaziland
by: Mhlongo, Gladys Thembinkosi
Published: (2009)

BUTIMBA: Intensifying the Hunt for Child TB in Swaziland through Household Contact Tracing.
by: Anna Maria Mandalakas, et al.
Published: (2017-01-01)

Predictors of suboptimal adherence to isoniazid preventive therapy among adolescents and children living with HIV.
by: Alexander W Kay, et al.
Published: (2020-01-01)

Art therapy: an underutilized, yet effective tool
by: Robert A. Bitonte, et al.
Published: (2014-03-01)

Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South Africa.
by: Liesl Page-Shipp, et al.
Published: (2018-01-01)

Implementing an isoniazid preventive therapy program for people living with HIV in Thailand.
by: Junya Danyuttapolchai, et al.
Published: (2017-01-01)

Isoniazid preventive therapy for HIV infected children: Impact on incidence of tuberculosis?
by: C.D. Mitchell
Published: (2014-04-01)

Single tube single-color analysis of rifampicin and isoniazid allelic variants in MDR-TB
by: L. Wangh, et al.
Published: (2014-04-01)

Nanoparticle-Formulated Curcumin Prevents Posttherapeutic Disease Reactivation and Reinfection with Mycobacterium tuberculosis following Isoniazid Therapy
by: Sultan Tousif, et al.
Published: (2017-06-01)

School and household tuberculosis contact investigations in Swaziland: Active TB case finding in a high HIV/TB burden setting.
by: Piluca Alonzo Ustero, et al.
Published: (2017-01-01)

Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso
by: Pinsi Gabriele, et al.
Published: (2009-08-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
by: Randall S Stafford, et al.
Published: (2005-12-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
Published: (2005-12-01)

Factors associated with isoniazid resistant tuberculosis among human immunodeficiency virus positive patients in Swaziland: a case-control study
by: Nonhlanhla Christinah Dlamini, et al.
Published: (2019-08-01)